Aclaris Therapeutics Inc.

NASDAQ: ACRSHealthcare / Biotechnology / USA
4.45-0.0900-1.98%Vol 342 6901Y Perf -76.97%
Jun 24th, 2019 16:00
BID4.28 ASK5.05
Open4.55 Previous Close4.54
Pre-Market- After-Trading-
 - -%  - -%
Target Price
26.40 
Analyst Rating
Strong Buy 1.00
Potencial %
493.26 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/100 
Income Ranking
 —    -
Market Cap (mil)184 
Earnings Rating
Sell
Price Range Ratio 52wk %
1.02 
Earnings Date
2nd Aug 2019

Today's Price Range

4.354.67

52wk Range

4.2721.97

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-13.09%
3 Months
-25.08%
6 Months
-34.94%
1 Year
-76.97%
3 Years
-75.41%
5 Years
-

Name / TickerPriceChg.Chg.%
ACRS4.45-0.0900-1.98
AAPL198.58-0.2000-0.10
GOOG1 115.52-6.3600-0.57
MSFT137.780.81000.59
XOM76.95-0.7400-0.95
WFC46.27-0.6200-1.32
JNJ143.060.97000.68
FB192.601.46000.76
GE10.28-0.2000-1.91
JPM108.66-0.7800-0.71
Earnings HistoryEstimateReportedSurprise %
Q01 2019-0.80-0.91-13.75
Q04 2018-0.96-0.99-3.12
Q03 2018-1.25-1.0615.20
Q02 2018-0.95-1.01-6.32
Q01 2018-0.99-0.981.01
Q04 2017-0.90-0.8011.11
Q03 2017-0.86-0.6326.74
Q02 2017-0.68-0.5617.65
Earnings Per EndEstimateRevision %Trend
6/2019 QR-0.77-2.67Negative
9/2019 QR-0.73-5.80Negative
12/2019 FY-2.98-2.41Negative
12/2020 FY-2.62-3.56Negative
Next Report Date2nd Aug 2019
Estimated EPS Next Report-0.77
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume342 690
Shares Outstanding (in ths.)41 272
Trades Count1 485
Dollar Volume1 323 312
Avg. Volume509 652
Avg. Weekly Volume444 053
Avg. Monthly Volume409 878
Avg. Quarterly Volume501 638
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
5 (100.00 %)
5 (100.00 %)
4 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Aclaris Therapeutics Inc.

Aclaris Therapeutics Inc is a clinical-stage specialty pharmaceutical company which operates in United States. It focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology. The company holds a drug candidate, A-101 Topical Solution which is a proprietary high-concentration hydrogen peroxide topical solution which is being developed as a prescription treatment for seborrheic keratosis (SK) a common non-malignant skin tumor. Its pipeline of drug candidates includes A-101 as a Topical Solution for treatment of SK, common warts; A-102 as a gel dosage form for treatment of SK and warts and A-201 and A-301 as an oral and topical formulation for treatment of autoimmune dermatologic respectively.

CEO: Neal Walker

Teplephone: +1 484 324-7933

Address: 640 Lee Road, Wayne 19087, PA, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

48%52%

Bearish Bullish

59%41%

Bearish Bullish

61%39%

News